Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:08 pm
| PEG Ratio | 5.41 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ambuja Cements Ltd, a key player in the Indian cement industry, reported a market capitalization of ₹1,37,161 Cr and a share price of ₹555. The company’s sales have displayed a robust upward trajectory, with a recorded total of ₹38,937 Cr for the financial year ending March 2023, which rose to ₹33,160 Cr in March 2024 and is projected to reach ₹35,045 Cr by March 2025. The trailing twelve months (TTM) revenue stood at ₹37,114 Cr. Quarterly sales have shown variability, with the highest quarterly sales of ₹10,289 Cr reported in June 2025. The company’s operational efficiency is highlighted by an operating profit margin (OPM) of 19% and a cash conversion cycle (CCC) of 100 days, indicative of effective inventory and receivables management. In a sector where OPM typically ranges between 15% and 20%, Ambuja’s performance positions it favorably against its peers.
Profitability and Efficiency Metrics
Ambuja Cements reported a net profit of ₹5,345 Cr and an impressive return on equity (ROE) of 8.73%, reflecting effective management of shareholder funds. The company’s operating profit for the financial year ending March 2024 was ₹6,400 Cr, with a profit before tax of ₹5,896 Cr. The OPM has shown fluctuations, reaching a peak of 21% in December 2023, which is above the industry average. The interest coverage ratio (ICR) stood at an exceptional 45.06x, indicating a strong ability to meet interest obligations, which is significantly higher than the typical range of 2-4x for the sector. However, one risk factor is the declining net profit margin, which fell to 14.68% in March 2025 from 18% in March 2024. This trend suggests increasing cost pressures that could affect future profitability.
Balance Sheet Strength and Financial Ratios
Ambuja Cements maintains a solid balance sheet, with total assets reported at ₹80,941 Cr as of March 2025. The company’s reserves have increased to ₹52,951 Cr, reflecting a strong capital base. Borrowings stood at ₹788 Cr, indicating prudent debt management within a low leverage framework. The company’s current ratio of 1.42x suggests adequate liquidity to cover short-term liabilities, while a quick ratio of 1.12x indicates a sound ability to meet immediate obligations without relying on inventory sales. The price-to-book value (P/BV) ratio was recorded at 2.96x, indicating that the stock is trading at a premium relative to its book value, which is typical for high-performing companies in the cement sector. However, the return on capital employed (ROCE) of 10.5% shows a decline compared to previous years, signaling potential inefficiencies in capital utilization that could be addressed.
Shareholding Pattern and Investor Confidence
The shareholding structure of Ambuja Cements reveals a strong promoter holding of 67.68%, which stabilizes governance and strategic direction. Foreign institutional investors (FIIs) accounted for 5.91%, while domestic institutional investors (DIIs) held 19.41%. The public holds a smaller 6.77% of shares, indicating a concentrated ownership that may affect liquidity. The number of shareholders increased to 620,457, reflecting growing retail interest and confidence in the company’s prospects. Over recent quarters, promoter ownership rose from 63.22% in March 2023 to 67.57% in March 2025, suggesting an increasing commitment to the company. However, a decline in FII participation from 10.66% in December 2022 to 5.91% in March 2025 raises concerns about the stock’s appeal in the international market, potentially affecting its valuation and investor sentiment.
Outlook, Risks, and Final Insight
Ambuja Cements appears well-positioned for continued growth, supported by strong revenue trends and a solid balance sheet. However, rising costs and declining profit margins pose significant risks that could hinder future performance. The company must navigate challenges such as fluctuating raw material prices and competitive pressures in the cement sector. Furthermore, shifts in investor sentiment, particularly among FIIs, could impact stock liquidity and valuation. The outlook remains contingent on the company’s ability to maintain operational efficiency, manage costs effectively, and adapt to changing market dynamics. If Ambuja can effectively leverage its strengths while mitigating risks, it has the potential to enhance shareholder value in the long term. Conversely, failure to address these challenges may lead to diminished profitability and investor confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambuja Cements Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 24.0/16.2 | 3.95 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,52,148 Cr. | 11,950 | 13,102/10,048 | 48.0 | 2,444 | 0.65 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 24,262 Cr. | 1,026 | 1,209/788 | 168 | 317 | 0.20 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 12,444 Cr. | 402 | 430/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 10,505 Cr. | 260 | 309/172 | 44.4 | 71.2 | 0.38 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 36,141.39 Cr | 2,000.77 | 42.12 | 568.41 | 0.50% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,033 | 7,143 | 7,907 | 7,966 | 8,713 | 7,424 | 8,129 | 8,894 | 8,392 | 7,516 | 9,329 | 9,981 | 10,289 |
| Expenses | 6,922 | 6,809 | 6,885 | 6,727 | 7,046 | 6,122 | 6,397 | 7,195 | 7,112 | 6,405 | 7,617 | 8,113 | 8,328 |
| Operating Profit | 1,111 | 334 | 1,021 | 1,239 | 1,667 | 1,302 | 1,732 | 1,699 | 1,280 | 1,111 | 1,712 | 1,868 | 1,961 |
| OPM % | 14% | 5% | 13% | 16% | 19% | 18% | 21% | 19% | 15% | 15% | 18% | 19% | 19% |
| Other Income | 143 | 75 | -18 | 142 | 268 | 480 | 204 | 448 | 358 | 220 | 1,355 | 713 | 300 |
| Interest | 40 | 41 | 43 | 39 | 52 | 61 | 70 | 93 | 68 | 67 | 67 | 14 | 67 |
| Depreciation | 319 | 331 | 337 | 352 | 372 | 381 | 416 | 459 | 476 | 552 | 664 | 786 | 862 |
| Profit before tax | 895 | 39 | 623 | 989 | 1,512 | 1,340 | 1,450 | 1,595 | 1,094 | 713 | 2,336 | 1,780 | 1,333 |
| Tax % | 3% | -33% | 22% | 23% | 25% | 26% | 25% | 5% | 28% | 34% | -12% | 28% | 27% |
| Net Profit | 865 | 51 | 488 | 763 | 1,135 | 987 | 1,091 | 1,521 | 783 | 473 | 2,620 | 1,282 | 970 |
| EPS in Rs | 3.79 | 0.47 | 2.19 | 3.25 | 4.56 | 3.99 | 4.15 | 4.78 | 2.60 | 1.85 | 8.59 | 3.88 | 3.20 |
Last Updated: August 2, 2025, 12:25 am
Below is a detailed analysis of the quarterly data for Ambuja Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 10,289.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,981.00 Cr. (Mar 2025) to 10,289.00 Cr., marking an increase of 308.00 Cr..
- For Expenses, as of Jun 2025, the value is 8,328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,113.00 Cr. (Mar 2025) to 8,328.00 Cr., marking an increase of 215.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 1,961.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,868.00 Cr. (Mar 2025) to 1,961.00 Cr., marking an increase of 93.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00%.
- For Other Income, as of Jun 2025, the value is 300.00 Cr.. The value appears to be declining and may need further review. It has decreased from 713.00 Cr. (Mar 2025) to 300.00 Cr., marking a decrease of 413.00 Cr..
- For Interest, as of Jun 2025, the value is 67.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 53.00 Cr..
- For Depreciation, as of Jun 2025, the value is 862.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 786.00 Cr. (Mar 2025) to 862.00 Cr., marking an increase of 76.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 1,333.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,780.00 Cr. (Mar 2025) to 1,333.00 Cr., marking a decrease of 447.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 27.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 970.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,282.00 Cr. (Mar 2025) to 970.00 Cr., marking a decrease of 312.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.20. The value appears to be declining and may need further review. It has decreased from 3.88 (Mar 2025) to 3.20, marking a decrease of 0.68.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:21 pm
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,161 | 9,955 | 9,437 | 20,094 | 23,609 | 26,041 | 27,104 | 24,516 | 28,965 | 38,937 | 33,160 | 35,045 | 37,114 |
| Expenses | 7,492 | 8,022 | 7,895 | 16,913 | 19,751 | 22,030 | 22,507 | 19,511 | 22,755 | 33,815 | 26,760 | 29,074 | 30,462 |
| Operating Profit | 1,669 | 1,934 | 1,542 | 3,181 | 3,858 | 4,011 | 4,597 | 5,006 | 6,210 | 5,122 | 6,400 | 5,971 | 6,652 |
| OPM % | 18% | 19% | 16% | 16% | 16% | 15% | 17% | 20% | 21% | 13% | 19% | 17% | 18% |
| Other Income | 390 | 419 | 353 | 441 | 335 | 232 | 601 | 288 | 252 | 447 | 1,401 | 2,646 | 2,588 |
| Interest | 67 | 66 | 92 | 153 | 206 | 170 | 170 | 140 | 146 | 195 | 276 | 216 | 215 |
| Depreciation | 494 | 513 | 630 | 1,461 | 1,219 | 1,154 | 1,153 | 1,162 | 1,152 | 1,645 | 1,628 | 2,478 | 2,864 |
| Profit before tax | 1,498 | 1,774 | 1,173 | 2,008 | 2,768 | 2,919 | 3,875 | 3,992 | 5,164 | 3,729 | 5,896 | 5,922 | 6,161 |
| Tax % | 15% | 16% | 31% | 29% | 30% | -2% | 28% | 22% | 28% | 19% | 20% | 13% | |
| Net Profit | 1,278 | 1,487 | 808 | 1,434 | 1,945 | 2,973 | 2,783 | 3,107 | 3,711 | 3,024 | 4,735 | 5,158 | 5,345 |
| EPS in Rs | 8.27 | 9.59 | 5.21 | 5.57 | 7.64 | 10.97 | 10.55 | 11.91 | 14.00 | 13.01 | 16.26 | 16.92 | 17.52 |
| Dividend Payout % | 44% | 46% | 54% | 50% | 47% | 14% | 14% | 151% | 45% | 19% | 12% | 12% |
YoY Net Profit Growth
| Year | 2024-2025 |
|---|---|
| YoY Net Profit Growth (%) | 8.93% |
| Change in YoY Net Profit Growth (%) | 0.00% |
Ambuja Cements Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 22% |
| 3 Years: | 11% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 4, 2025, 11:10 pm
Balance Sheet
Last Updated: October 10, 2025, 1:37 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 309 | 310 | 310 | 397 | 397 | 397 | 397 | 397 | 397 | 397 | 440 | 493 |
| Reserves | 9,153 | 9,760 | 9,961 | 19,424 | 20,275 | 21,973 | 23,681 | 22,360 | 24,957 | 31,301 | 41,012 | 52,951 |
| Borrowings | 48 | 34 | 35 | 29 | 24 | 40 | 41 | 471 | 477 | 523 | 699 | 788 |
| Other Liabilities | 3,446 | 3,774 | 3,827 | 12,974 | 14,813 | 14,981 | 16,059 | 16,490 | 19,374 | 19,501 | 22,916 | 26,709 |
| Total Liabilities | 12,956 | 13,878 | 14,133 | 32,824 | 35,509 | 37,391 | 40,178 | 39,718 | 45,205 | 51,721 | 65,067 | 80,941 |
| Fixed Assets | 6,147 | 6,310 | 6,170 | 21,410 | 20,898 | 20,636 | 20,701 | 20,486 | 22,254 | 23,551 | 32,194 | 42,578 |
| CWIP | 698 | 692 | 416 | 582 | 667 | 1,008 | 1,554 | 2,422 | 2,168 | 2,526 | 2,658 | 9,886 |
| Investments | 1,714 | 2,097 | 2,149 | 175 | 153 | 133 | 150 | 167 | 198 | 214 | 849 | 1,912 |
| Other Assets | 4,399 | 4,780 | 5,398 | 10,657 | 13,791 | 15,613 | 17,773 | 16,643 | 20,585 | 25,430 | 29,365 | 26,566 |
| Total Assets | 12,956 | 13,878 | 14,133 | 32,824 | 35,509 | 37,391 | 40,178 | 39,718 | 45,205 | 51,721 | 65,067 | 80,941 |
Below is a detailed analysis of the balance sheet data for Ambuja Cements Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 493.00 Cr.. The value appears strong and on an upward trend. It has increased from 440.00 Cr. (Mar 2024) to 493.00 Cr., marking an increase of 53.00 Cr..
- For Reserves, as of Mar 2025, the value is 52,951.00 Cr.. The value appears strong and on an upward trend. It has increased from 41,012.00 Cr. (Mar 2024) to 52,951.00 Cr., marking an increase of 11,939.00 Cr..
- For Borrowings, as of Mar 2025, the value is 788.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 699.00 Cr. (Mar 2024) to 788.00 Cr., marking an increase of 89.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 26,709.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22,916.00 Cr. (Mar 2024) to 26,709.00 Cr., marking an increase of 3,793.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 80,941.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 65,067.00 Cr. (Mar 2024) to 80,941.00 Cr., marking an increase of 15,874.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 42,578.00 Cr.. The value appears strong and on an upward trend. It has increased from 32,194.00 Cr. (Mar 2024) to 42,578.00 Cr., marking an increase of 10,384.00 Cr..
- For CWIP, as of Mar 2025, the value is 9,886.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,658.00 Cr. (Mar 2024) to 9,886.00 Cr., marking an increase of 7,228.00 Cr..
- For Investments, as of Mar 2025, the value is 1,912.00 Cr.. The value appears strong and on an upward trend. It has increased from 849.00 Cr. (Mar 2024) to 1,912.00 Cr., marking an increase of 1,063.00 Cr..
- For Other Assets, as of Mar 2025, the value is 26,566.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29,365.00 Cr. (Mar 2024) to 26,566.00 Cr., marking a decrease of 2,799.00 Cr..
- For Total Assets, as of Mar 2025, the value is 80,941.00 Cr.. The value appears strong and on an upward trend. It has increased from 65,067.00 Cr. (Mar 2024) to 80,941.00 Cr., marking an increase of 15,874.00 Cr..
Notably, the Reserves (52,951.00 Cr.) exceed the Borrowings (788.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023n n 15m | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -47.00 | -33.00 | -34.00 | -26.00 | -21.00 | -36.00 | -37.00 | -466.00 | -471.00 | 5.00 | -693.00 | -783.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 8 | 11 | 17 | 14 | 18 | 14 | 8 | 8 | 11 | 13 | 17 |
| Inventory Days | 419 | 379 | 394 | 339 | 323 | 333 | 208 | 193 | 337 | 234 | 238 | 238 |
| Days Payable | 251 | 265 | 299 | 324 | 370 | 339 | 231 | 259 | 359 | 198 | 196 | 154 |
| Cash Conversion Cycle | 176 | 123 | 107 | 32 | -33 | 13 | -9 | -58 | -14 | 46 | 56 | 100 |
| Working Capital Days | -54 | -61 | -65 | -67 | -62 | -34 | -56 | -80 | -74 | 45 | 8 | -22 |
| ROCE % | 16% | 18% | 11% | 11% | 12% | 12% | 14% | 14% | 17% | 12% | 13% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Mirae Asset Large Cap Fund | 9,478,894 | 1.4 | 531.1 | 9,478,894 | 2025-04-22 17:25:42 | 0% |
| Mirae Asset ELSS Tax Saver Fund | 6,828,859 | 1.83 | 382.62 | 6,828,859 | 2025-04-22 17:25:42 | 0% |
| ICICI Prudential Equity - Arbitrage Fund | 4,107,600 | 1.41 | 230.15 | 4,107,600 | 2025-04-22 17:25:42 | 0% |
| Kotak Equity Arbitrage Fund - Regular Plan | 3,819,600 | 0.59 | 214.01 | 3,819,600 | 2025-04-22 17:25:42 | 0% |
| Kotak Balanced Advantage Fund | 3,712,800 | 1.33 | 208.03 | 3,712,800 | 2025-04-22 17:25:42 | 0% |
| Nippon India Arbitrage Fund | 3,186,000 | 1.37 | 178.51 | 3,186,000 | 2025-04-22 17:25:42 | 0% |
| SBI Arbitrage Opportunities Fund | 3,164,400 | 0.67 | 177.3 | 3,164,400 | 2025-04-22 17:25:42 | 0% |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 3,038,765 | 1.14 | 170.26 | 3,038,765 | 2025-04-22 17:25:42 | 0% |
| HDFC Large and Mid Cap Fund - Regular Plan | 2,949,329 | 1.03 | 165.25 | 2,949,329 | 2025-04-22 17:25:42 | 0% |
| Kotak Multicap Fund | 2,828,789 | 1.77 | 158.5 | 2,828,789 | 2025-04-22 17:25:42 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 17.00 | 17.99 | 13.01 | 14.00 | 11.91 |
| Diluted EPS (Rs.) | 16.96 | 16.67 | 12.64 | 14.00 | 11.91 |
| Cash EPS (Rs.) | 30.95 | 28.84 | 23.37 | 24.39 | 21.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 216.98 | 231.36 | 195.18 | 163.67 | 146.54 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 216.98 | 231.36 | 195.18 | 163.67 | 146.54 |
| Revenue From Operations / Share (Rs.) | 142.28 | 150.88 | 196.09 | 145.87 | 123.47 |
| PBDIT / Share (Rs.) | 35.02 | 34.43 | 29.51 | 33.05 | 27.47 |
| PBIT / Share (Rs.) | 24.95 | 27.04 | 21.23 | 27.25 | 21.62 |
| PBT / Share (Rs.) | 23.99 | 26.74 | 18.64 | 25.91 | 20.03 |
| Net Profit / Share (Rs.) | 20.89 | 21.45 | 15.09 | 18.59 | 15.57 |
| NP After MI And SOA / Share (Rs.) | 16.92 | 16.27 | 13.01 | 14.00 | 11.91 |
| PBDIT Margin (%) | 24.61 | 22.81 | 15.05 | 22.65 | 22.25 |
| PBIT Margin (%) | 17.53 | 17.92 | 10.82 | 18.67 | 17.51 |
| PBT Margin (%) | 16.86 | 17.72 | 9.50 | 17.75 | 16.22 |
| Net Profit Margin (%) | 14.68 | 14.21 | 7.69 | 12.74 | 12.61 |
| NP After MI And SOA Margin (%) | 11.89 | 10.78 | 6.63 | 9.59 | 9.64 |
| Return on Networth / Equity (%) | 7.79 | 8.62 | 8.14 | 10.96 | 10.39 |
| Return on Capital Employeed (%) | 9.16 | 11.17 | 10.48 | 15.92 | 14.09 |
| Return On Assets (%) | 5.14 | 5.47 | 4.99 | 6.15 | 5.95 |
| Asset Turnover Ratio (%) | 0.47 | 0.56 | 0.49 | 0.41 | 0.34 |
| Current Ratio (X) | 1.42 | 2.05 | 1.67 | 1.52 | 1.38 |
| Quick Ratio (X) | 1.12 | 1.75 | 1.39 | 1.27 | 1.20 |
| Inventory Turnover Ratio (X) | 3.58 | 3.61 | 3.51 | 2.93 | 2.20 |
| Dividend Payout Ratio (NP) (%) | 11.82 | 13.87 | 48.42 | 0.00 | 142.70 |
| Dividend Payout Ratio (CP) (%) | 7.41 | 9.54 | 29.58 | 0.00 | 95.70 |
| Earning Retention Ratio (%) | 88.18 | 86.13 | 51.58 | 0.00 | -42.70 |
| Cash Earning Retention Ratio (%) | 92.59 | 90.46 | 70.42 | 0.00 | 4.30 |
| Interest Coverage Ratio (X) | 39.94 | 27.38 | 30.07 | 45.06 | 38.90 |
| Interest Coverage Ratio (Post Tax) (X) | 24.93 | 17.29 | 18.01 | 27.17 | 24.31 |
| Enterprise Value (Cr.) | 136725.29 | 132923.92 | 76710.60 | 70462.46 | 46861.76 |
| EV / Net Operating Revenue (X) | 3.90 | 4.01 | 1.97 | 2.43 | 1.91 |
| EV / EBITDA (X) | 15.85 | 17.57 | 13.09 | 10.74 | 8.59 |
| MarketCap / Net Operating Revenue (X) | 3.78 | 4.06 | 1.86 | 2.59 | 2.02 |
| Retention Ratios (%) | 88.17 | 86.12 | 51.57 | 0.00 | -42.70 |
| Price / BV (X) | 2.48 | 3.25 | 2.29 | 2.96 | 2.17 |
| Price / Net Operating Revenue (X) | 3.78 | 4.06 | 1.86 | 2.59 | 2.02 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Ambuja Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.00. This value is within the healthy range. It has decreased from 17.99 (Mar 24) to 17.00, marking a decrease of 0.99.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 16.96, marking an increase of 0.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 30.95. This value is within the healthy range. It has increased from 28.84 (Mar 24) to 30.95, marking an increase of 2.11.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.98. It has decreased from 231.36 (Mar 24) to 216.98, marking a decrease of 14.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 216.98. It has decreased from 231.36 (Mar 24) to 216.98, marking a decrease of 14.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.28. It has decreased from 150.88 (Mar 24) to 142.28, marking a decrease of 8.60.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.02. This value is within the healthy range. It has increased from 34.43 (Mar 24) to 35.02, marking an increase of 0.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 24.95. This value is within the healthy range. It has decreased from 27.04 (Mar 24) to 24.95, marking a decrease of 2.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.99. This value is within the healthy range. It has decreased from 26.74 (Mar 24) to 23.99, marking a decrease of 2.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 20.89. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 20.89, marking a decrease of 0.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.92. This value is within the healthy range. It has increased from 16.27 (Mar 24) to 16.92, marking an increase of 0.65.
- For PBDIT Margin (%), as of Mar 25, the value is 24.61. This value is within the healthy range. It has increased from 22.81 (Mar 24) to 24.61, marking an increase of 1.80.
- For PBIT Margin (%), as of Mar 25, the value is 17.53. This value is within the healthy range. It has decreased from 17.92 (Mar 24) to 17.53, marking a decrease of 0.39.
- For PBT Margin (%), as of Mar 25, the value is 16.86. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 16.86, marking a decrease of 0.86.
- For Net Profit Margin (%), as of Mar 25, the value is 14.68. This value exceeds the healthy maximum of 10. It has increased from 14.21 (Mar 24) to 14.68, marking an increase of 0.47.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.89. This value is within the healthy range. It has increased from 10.78 (Mar 24) to 11.89, marking an increase of 1.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.79. This value is below the healthy minimum of 15. It has decreased from 8.62 (Mar 24) to 7.79, marking a decrease of 0.83.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has decreased from 11.17 (Mar 24) to 9.16, marking a decrease of 2.01.
- For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has decreased from 5.47 (Mar 24) to 5.14, marking a decrease of 0.33.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.56 (Mar 24) to 0.47, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has decreased from 2.05 (Mar 24) to 1.42, marking a decrease of 0.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.12. This value is within the healthy range. It has decreased from 1.75 (Mar 24) to 1.12, marking a decrease of 0.63.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.58. This value is below the healthy minimum of 4. It has decreased from 3.61 (Mar 24) to 3.58, marking a decrease of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.82. This value is below the healthy minimum of 20. It has decreased from 13.87 (Mar 24) to 11.82, marking a decrease of 2.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 20. It has decreased from 9.54 (Mar 24) to 7.41, marking a decrease of 2.13.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.18. This value exceeds the healthy maximum of 70. It has increased from 86.13 (Mar 24) to 88.18, marking an increase of 2.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.59. This value exceeds the healthy maximum of 70. It has increased from 90.46 (Mar 24) to 92.59, marking an increase of 2.13.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 39.94. This value is within the healthy range. It has increased from 27.38 (Mar 24) to 39.94, marking an increase of 12.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 24.93. This value is within the healthy range. It has increased from 17.29 (Mar 24) to 24.93, marking an increase of 7.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 136,725.29. It has increased from 132,923.92 (Mar 24) to 136,725.29, marking an increase of 3,801.37.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 4.01 (Mar 24) to 3.90, marking a decrease of 0.11.
- For EV / EBITDA (X), as of Mar 25, the value is 15.85. This value exceeds the healthy maximum of 15. It has decreased from 17.57 (Mar 24) to 15.85, marking a decrease of 1.72.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.78, marking a decrease of 0.28.
- For Retention Ratios (%), as of Mar 25, the value is 88.17. This value exceeds the healthy maximum of 70. It has increased from 86.12 (Mar 24) to 88.17, marking an increase of 2.05.
- For Price / BV (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has decreased from 3.25 (Mar 24) to 2.48, marking a decrease of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.06 (Mar 24) to 3.78, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambuja Cements Ltd:
- Net Profit Margin: 14.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.16% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.79% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 24.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.12
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.8 (Industry average Stock P/E: 42.12)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Adani Corporate House, Shantigram, Near Vaishnavdevi Circle, Ahmedabad Gujarat 382421 | investors.relation@adani.com https://www.ambujacement.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gautam Adani | NonExeChairman&NonInd.Director |
| Mr. Ajay Kapur | Managing Director |
| Mr. Vinod Bahety | WholeTime Director & CEO |
| Mr. Karan Adani | Non Exe.Non Ind.Director |
| Mr. M R Kumar | Non Exe.Non Ind.Director |
| Mr. Rajnish Kumar | Ind. Non-Executive Director |
| Mr. Maheswar Sahu | Ind. Non-Executive Director |
| Ms. Purvi Sheth | Ind. Non-Executive Director |
| Mr. Ameet Desai | Ind. Non-Executive Director |
| Mr. Praveen Garg | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Ambuja Cements Ltd?
Ambuja Cements Ltd's intrinsic value (as of 03 November 2025) is 396.29 which is 31.32% lower the current market price of 577.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,42,712 Cr. market cap, FY2025-2026 high/low of 625/453, reserves of ₹52,951 Cr, and liabilities of 80,941 Cr.
What is the Market Cap of Ambuja Cements Ltd?
The Market Cap of Ambuja Cements Ltd is 1,42,712 Cr..
What is the current Stock Price of Ambuja Cements Ltd as on 03 November 2025?
The current stock price of Ambuja Cements Ltd as on 03 November 2025 is 577.
What is the High / Low of Ambuja Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambuja Cements Ltd stocks is 625/453.
What is the Stock P/E of Ambuja Cements Ltd?
The Stock P/E of Ambuja Cements Ltd is 24.8.
What is the Book Value of Ambuja Cements Ltd?
The Book Value of Ambuja Cements Ltd is 228.
What is the Dividend Yield of Ambuja Cements Ltd?
The Dividend Yield of Ambuja Cements Ltd is 0.35 %.
What is the ROCE of Ambuja Cements Ltd?
The ROCE of Ambuja Cements Ltd is 10.5 %.
What is the ROE of Ambuja Cements Ltd?
The ROE of Ambuja Cements Ltd is 8.73 %.
What is the Face Value of Ambuja Cements Ltd?
The Face Value of Ambuja Cements Ltd is 2.00.
